Support: (+212) 622021832 - Email:
In our first-in-human examination we watched a beneficial outcome of ProtEmbo on patient's minds with a decrease of around half in cerebrum injury trouble contrasted with patients without cerebral assurance. While altering for pre-procedural injury trouble the ProtEmbo showed an up to 90% decrease.

Medgadget: How does utilization of the ProtEmbo influence the medical procedure work process or present any extra careful dangers?

Protembis: The ProtEmbo System is a natural aide gadget to be utilized during TAVR. It very well may be conveyed through a monetarily accessible 6F sheath by means of the left arm of a patient. The vascular access for ProtEmbo can be led while the patient is being set up for TAVR. The ProtEmbo vascular access is disengaged from all other interventional gear, leaving particularly the crotch femoral access free for any sort of joined interventional systems. Situation of the channel is incredibly speedy and simple, adding no huge time to the general strategy. Likewise, utilizing the left spiral access involves less dangers, for example, draining and utilization of extra conclusion gadgets.

Medgadget: At what stage is the organization today?

Protembis: Today, Protembis has a group of 10+ individuals and is setting up an European clinical investigation with its cutting edge ProtEmbo System. The latest subsidizing was finished in late 2018 with a $10 million Series A financing round. A syndicate comprising of VCs, family workplaces and medtech holy messenger financial specialists together with US medtech organization Abiomed Inc. had contributed in those days. This last subsidizing round makes sure about the following stages through CE stamping of the ProtEmbo System.

Medgadget: What are probably the greatest difficulties confronting the group throughout the following not many years?

Protembis: The greatest test for us – with respect to any medtech startup at a similar stage – is positively the progress to Medical Devices Regulation (MDR). We at Protembis have taken the key choice not to endeavor sneaking past under Medical Device Directive (MDD) yet to experience the similarity evaluation for our item under MDR. This involves extra obstacles yet we consider this to be an upper hand for our organization. MDR carries prerequisites closer to FDA standard and will expand trust in our items. Following CE mark endorsement, Protembis plans to direct a bigger clinical preliminary in the United States for FDA endorsement of the ProtEmbo.